We are live on ! Find out more
CWP

Concord Wealth Partners Portfolio holdings

AUM $873M
1-Year Est. Return 24.02%
This Fund
S&P 500
This Quarter Est. Return
+4.05%
1 Year Est. Return
+24.02%
3 Year Est. Return
+66.02%
5 Year Est. Return
+59.32%
10 Year Est. Return
–
AUM
$349M
AUM Growth
+$52M
Cap. Flow
+$39.8M
Cap. Flow %
11.4%
Top 10 Hldgs %
63.1%
Holding
1,129
New
109
Increased
346
Reduced
275
Closed
81

Top Buys

Rank Stock Value
1
VGIT icon
Vanguard Intermediate-Term Treasury ETF
VGIT
+$9.47M
2
SPMB icon
State Street SPDR Portfolio Mortgage Backed Bond ETF
SPMB
+$5.08M
3
VCIT icon
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
+$4.76M
4
DGRO icon
iShares Core Dividend Growth ETF
DGRO
+$4.31M
5
SPDW icon
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
+$4.19M

Top Sells

Rank Stock Value
1
DON icon
WisdomTree US MidCap Dividend Fund
DON
+$7.11M
2
MUB icon
iShares National Muni Bond ETF
MUB
+$3.57M
3
NUMV icon
Nuveen ESG Mid-Cap Value ETF
NUMV
+$922K
4
VTEB icon
Vanguard Tax-Exempt Bond Index Fund
VTEB
+$794K
5
LMBS icon
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
+$423K

Sector Composition

Rank Sector Weight
1 Technology 6.43%
2 Financials 5.05%
3 Healthcare 3.29%
4 Consumer Discretionary 3.07%
5 Communication Services 2.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WLY icon
926
John Wiley & Sons Class A
WLY
$2.66B
$2K ﹤0.01%
28
– –
XRX icon
927
Xerox
XRX
$456M
$2K ﹤0.01%
+67
New +$1.62K
TUP
928
DELISTED
Tupperware Brands Corporation
TUP
$2K ﹤0.01%
100
– –
CAMP
929
DELISTED
CalAmp Corp.
CAMP
$2K ﹤0.01%
+6
New +$1.79K
ORTX
930
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$2K ﹤0.01%
40
+20
+100% +$1.11K
UMPQ
931
DELISTED
Umpqua Holdings Corp
UMPQ
$2K ﹤0.01%
97
– –
TPTX
932
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$2K ﹤0.01%
28
– –
DRNA
933
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$2K ﹤0.01%
59
– –
XLRN
934
DELISTED
Acceleron Pharma
XLRN
$2K ﹤0.01%
16
– –
CCMP
935
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$2K ﹤0.01%
16
– –
BHVN
936
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$2K ﹤0.01%
21
– –
AGYS icon
937
Agilysys
AGYS
$3.04B
$1K ﹤0.01%
+21
New +$1.09K
ALLO icon
938
Allogene Therapeutics
ALLO
$680M
$1K ﹤0.01%
24
– –
AREC icon
939
American Resources Corp
AREC
$196M
$1K ﹤0.01%
500
– –
ARWR icon
940
Arrowhead Research
ARWR
$12.3B
$1K ﹤0.01%
13
– –
EFOR
941
Everforth Inc
EFOR
$1.13B
$1K ﹤0.01%
13
+1
+8% +$102
ATHM icon
942
Autohome
ATHM
$2.63B
$1K ﹤0.01%
12
– –
ATI icon
943
ATI
ATI
$24.8B
$1K ﹤0.01%
61
– –
AUB icon
944
Atlantic Union Bankshares
AUB
$6B
$1K ﹤0.01%
31
– –
BAH icon
945
Booz Allen Hamilton
BAH
$8.22B
$1K ﹤0.01%
13
– –
BHF icon
946
Brighthouse Financial
BHF
$3.64B
$1K ﹤0.01%
12
+7
+140% +$329
BIO icon
947
Bio-Rad Laboratories Class A
BIO
$8.74B
$1K ﹤0.01%
2
– –
BLRX
948
BioLineRX
BLRX
$11.7M
$1K ﹤0.01%
5
-20
-80% -$2.35K
BMRN icon
949
BioMarin Pharmaceuticals
BMRN
$11.7B
$1K ﹤0.01%
9
– –
CCL icon
950
Carnival Corporation Ltd
CCL
$38B
$1K ﹤0.01%
50
-1
-2% -$28
36 37
38
39 40

Similar funds

PAI
Power Alpha Investment Road Town, Tortola, British Virgin Islands $874M AUM
SA
SoftVest Advisors Abilene, Texas $872M AUM 28.76% 1-Year Est. Return
F1I
Fund 1 Investments Rincon, Puerto Rico $872M AUM 50.95% 1-Year Est. Return
ACA
Atlas Capital Advisors Jackson, Wyoming $875M AUM
BFA
Boulay Financial Advisors Eden Prairie, Minnesota $871M AUM 17.11% 1-Year Est. Return
WCM
Wallace Capital Management Dallas, Texas $871M AUM 13.69% 1-Year Est. Return
RWA
River Wealth Advisors Camp Hill, Pennsylvania $871M AUM 20.5% 1-Year Est. Return
PLFA
Pacific Life Fund Advisors Newport Beach, California $871M AUM 16.29% 1-Year Est. Return

Concord Wealth Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Concord Wealth Partners held 1,129 positions worth $349M, up 18% from $297M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Concord Wealth Partners deployed $39.8M of net new capital in Q2 2021, opening 109 new positions and adding to 346 existing holdings. Its largest new stake was Nuveen ESG Large-Cap Value ETF: 34,640 shares worth $1.31M.

By sector, the portfolio is most concentrated in Technology at 6.4% of assets, down from 6.5% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was WisdomTree US MidCap Dividend Fund, an estimated $7.11M trimmed.

  • Concord Wealth Partners's largest Q2 2021 buy was Nuveen ESG Large-Cap Value ETF: 34,640 shares worth $1.31M.
  • Concord Wealth Partners added most to Vanguard Intermediate-Term Treasury ETF in Q2 2021, an estimated $9.47M increase.
  • Concord Wealth Partners's biggest Q2 2021 reduction was WisdomTree US MidCap Dividend Fund, cutting an estimated $7.11M.
  • Concord Wealth Partners fully exited Vanguard Tax-Exempt Bond Index Fund in Q2 2021, selling an estimated $794K.
  • Concord Wealth Partners's ten largest holdings make up 63% of its $349M portfolio in Q2 2021.
  • Concord Wealth Partners opened 109 new positions and closed 81 in Q2 2021.
  • Concord Wealth Partners's portfolio value rose 18% quarter-over-quarter to $349M.

Based on Concord Wealth Partners's 13F filing for Q2 2021, filed 29 Jul 2021.